Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Quest Diagnostics Incorporated, 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Quest Diagnostics Incorporated May 20, 202699.8%
-
Quest Diagnostics Incorporated May 15, 202599.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 21, 2026 | Quest Diagnostics Incorporated | Small acquisition | +10 | $235.93 | $2,359 |
| Jul 22, 2026 | Quest Diagnostics Incorporated | Small acquisition | +11 | $206.80 | $2,275 |
| May 20, 2026 | Quest Diagnostics Incorporated | Grant or award | +1,142 | — | — |
| Apr 20, 2026 | Quest Diagnostics Incorporated | Small acquisition | +7 | $194.70 | $1,363 |
| Jan 28, 2026 | Quest Diagnostics Incorporated | Small acquisition | +6 | $183.51 | $1,101 |
| Oct 21, 2025 | Quest Diagnostics Incorporated | Grant or award | +6 | $189.09 | $1,135 |
| Jul 21, 2025 | Quest Diagnostics Incorporated | Small acquisition | +7 | $167.51 | $1,173 |
| May 15, 2025 | Quest Diagnostics Incorporated | Grant or award | +1,203 | — | — |
| Jun 28, 2024 | FedEx Corporation | Option exercise | +16,010 | $180.82 | $2,894,928 |
| Jun 28, 2024 | FedEx Corporation | Open-market sale | −16,010 | $294.48 | $4,714,625 |
| Jun 27, 2024 | FedEx Corporation | Grant or award | +1,009 | — | — |
| May 16, 2024 | Quest Diagnostics Incorporated | Grant or award | +1,482 | — | — |
Questions about Robert B. Carter
What boards is Robert B. Carter on?
Robert B. Carter sits on the board of Quest Diagnostics Incorporated.
How long has Robert B. Carter served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.